cholesta-5,8-dien-3 beta-ol has been researched along with Mental Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caswell, R; Dobbie, A; Hartill, VL; Hobson, E; Koster, J; Manning, N; Santra, S; Tysoe, C; Walter, J; Waterham, H | 1 |
| Armstrong, K; Konradi, C; Korade, Ž; Liu, W; Porter, NA; Warren, EB | 1 |
2 other study(ies) available for cholesta-5,8-dien-3 beta-ol and Mental Disorders
| Article | Year |
|---|---|
An unusual phenotype of X-linked developmental delay and extreme behavioral difficulties associated with a mutation in the EBP gene.
Topics: Adult; Child; Cholestadienols; Developmental Disabilities; Genes, X-Linked; Genetic Diseases, X-Linked; Humans; Infant; Male; Mental Disorders; Mutation; Pedigree; Phenotype; Steroid Isomerases; Young Adult | 2014 |
Effect of psychotropic drug treatment on sterol metabolism.
Topics: Adult; Animals; Antidepressive Agents; Antipsychotic Agents; Body Mass Index; Cholestadienols; Clozapine; Dehydrocholesterols; Female; Haloperidol; Humans; Lipid Metabolism; Male; Mental Disorders; Psychiatric Status Rating Scales; Random Allocation; Rats, Sprague-Dawley; Weight Gain | 2017 |